Fig. 2From: A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in ChinaAverage HER2 signals and average CEP17 signals of two ASCO/CAP groups. The average HER2 copy number of ASCO/CAP group 2 was significantly higher than that of ASCO/CAP group 5 (p < 0.0001, A), while the average CEP17 copy number was significantly lower than ASCO/CAP group 5 (p < 0.0001, B)Back to article page